Fredun Pharmaceuticals Accelerates into a High-Growth Branded Healthcare Platform
Two Strategic Pet-Care Deals, Premium Wellness Launches, Capacity Expansion & Bonus Issue Position Company for the Next Leg of Growth Mumbai (Maharashtra) [India], October 8: Fredun Pharmaceuticals Limited (BSE: 539730) is rapidly transforming from a conventional manufacturing-led pharmaceutical company into a brand-led healthcare platform, with H1 FY27 marking a decisive phase of expansion across pet […]
Continue Reading